Method for minimally invasive, cell-selective laser therapy on the eye
AssigneeCarl Zeiss Meditec AG
InventorsManfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
Life of this patent
Estimating the term…
Loading patent…
AssigneeCarl Zeiss Meditec AG
InventorsManfred DICK, Gerald KUNATH-FANDREI, René DENNER, Thomas WURLITZER
Estimating the term…
A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 μs are provided for selective therapies and pulse lengths ranging from 50 μs to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source.
(canceled)
A laser system for a minimally invasive, cell-selective laser therapy at the eye, comprising:
A laser system for selective laser trabeculoplasty, wherein the solid-state laser emits individual pulses with pulse length in a range of 50 ns-500 ns, with spot sizes of 50 μm to 100 μm for an individual pulse, which are set in a dense packing, in particular as a square spot adjacent to each other, with a maximum pattern of 400×400 μm2.
Dependencies are inferred from the claim text.